Helen of Troy Limited

NASDAQ:HELE

Household & Personal Products

Consumer Defensive
$37.05 +1.76%

+$0.47 today

Market cap
$866.62M
Beta
1.33
P/E (TTM)
-0.7
EPS (TTM)
-$39.08
52W Low $13.85High $33.73

Volume 0.29M

Average 0.65M

HELE EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Helen of Troy LimitedNASDAQ: HELE

EBITDA · Q4 FY2026 · quarter ended Feb 2026

EBITDA turns negative

Q4 FY2026 EBITDA was -$37.23M, compared with $79.35M a year earlier. Trailing-twelve-month EBITDA was -$315.43M.

Context

  • EBITDA amounted to 40.7% of revenue in FY2026, up 26.7 pp from a year earlier.
  • EBITDA increased in 1 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 3 analysts of $206.52M (+128.4%) for the fiscal year ending Feb 2027, a step up from the -371.0% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$37.23M-895.8% QoQ
Last fiscal yearFeb 2026
-$727.8M-371.0% YoY
LTMFeb 2026
-$315.43M-218.2% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-146.9%-38.5%+108.4 pp
1 year-371.0%+128.4%+499.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2026
(727.8M) USD
Year-over-year change
-371.0%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How HELE compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -218.2% is the lowest of 11, against a peer median of -3.1%.
  • EBITDA amounts to 17.7% of revenue for HELE, versus a peer median of 18.2%.
HELE Competitors
EBITDA for HELE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PGThe Procter & Gamble CompanyLTM Sep 2026$24.48B USD-1.3%+3.9%27.8%
ULUnilever PLCFY2025€11.52B EUR-11.5%+2.9%22.8%
KVUEKenvue Inc.LTM Sep 2026$3.26B USD+10.9%-3.6%21.0%
CLXThe Clorox CompanyLTM Sep 2026$1.43B USD+8.6%+27.5%19.9%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$1.29B USD-5.3%+16.0%20.6%
REYNReynolds Consumer Products Inc.LTM Jun 2026$627M USD-4.9%+4.8%16.6%
NWLNewell Brands Inc.LTM Jun 2026$476M USD+37.6%-21.6%6.6%
EPCEdgewell Personal Care CompanyLTM Mar 2026$112.2M USD-58.4%-13.4%5.3%
HBBHamilton Beach Brands Holding CompanyLTM Mar 2026$46.03M USD+8.4%+0.1%7.7%
LCUTLifetime Brands, Inc.LTM Mar 2026$8.73M USD-74.9%-36.6%1.3%
HELEHelen of Troy LimitedLTM Feb 2026-$315.43M USD-218.2%—17.7%
Peer median (excluding HELE) —-3.1%+1.5%18.2%

Competitors are the stored peer set for HELE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Feb 2022
FY2023
Feb 2023
FY2024
Feb 2024
FY2025
Feb 2025
FY2026
Feb 2026
Revenue2.22B2.07B2.01B1.91B1.79B
Cost of Revenue1.27B1.17B1.06B993.26M970.6M
Gross Profit953.19M899.35M948.66M914.41M815.69M
Gross Margin42.9%43.4%47.3%47.9%45.7%
Research & Development54M47.8M56.5M53.9M54M
Selling, General & Admin611.03M595.9M621.74M622.65M708.91M
Operating Expenses680.64M687.56M688.07M771.66M708.91M
Depreciation & Amortization35.83M44.68M51.5M55.05M53.3M
EBITDA310.88M286.94M301.32M268.61M(727.8M)
EBITDA Margin14.0%13.8%15.0%14.1%-40.7%
Operating Income272.55M211.79M260.59M142.75M106.79M
Operating Margin12.3%10.2%13.0%7.5%6.0%
Interest Income00000
Interest Expense12.84M40.75M53.07M51.92M57.74M
Other Income / Expenses(12.58M)(40.5M)(51.55M)(51.08M)(945.62M)
Income Before Tax259.97M171.29M209.04M91.66M(838.84M)
Pre-Tax Margin11.7%8.3%10.4%4.8%-47.0%
Income Tax Expense36.2M28.02M40.45M(32.09M)60.14M
Net Income223.76M143.27M168.59M123.75M(898.98M)
Net Margin10.1%6.9%8.4%6.5%-50.3%
EPS (Basic)9.275.987.065.38(39.08)
EPS (Diluted)9.175.957.035.37(39.08)
Weighted Avg Shares24.4M24.08M23.98M23.04M23M
Weighted Avg Shares (Diluted)24.41M24.09M23.97M23.07M23M

Helen of Troy Limited

NASDAQ:HELE

Intrinsic Alpha fair value

Locked

Current Price

$37.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.